ResearcherYonsei UniversityActive in the last 2 years
Sang Hoon Lee
Matched on ORCID iD 0000-0002-3619-4340; OpenAlex author ID A5100349148. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 15
2016: 2 papers · 2017: 1 paper · 2018: none · 2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 2 papers
Papers 6
- Survival predictors in patients with pancreatic cancer on liposomal irinotecan plus fluorouracil/leucovorin: a multicenter observational study. Co-author DOI 10.1177/17588359241279688↗
- [Neoadjuvant Therapy for Resectable or Borderline Resectable Pancreatic Cancer]. Co-author DOI 10.4166/kjg.2024.079↗
- Plasma Chromogranin A as a Prognostic Marker in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1097/mpa.0000000000001319↗
- The Significance of the Prognostic Nutritional Index for All Stages of Pancreatic Cancer. Co-author DOI 10.1080/01635581.2016.1250921↗
- Can metformin change the prognosis of pancreatic cancer? Retrospective study for pancreatic cancer patients with pre-existing diabetes mellitus type 2. Co-author DOI 10.1016/j.dld.2015.12.006↗
- Statin Use and Its Impact on Survival in Pancreatic Cancer Patients. First author DOI 10.1097/md.0000000000003607↗
Closest collaborators
The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Seung Woo Park · 5 shared papers, 2016–2024 · strength 0.46
- Paper Survival predictors in patients with pancreatic cancer on liposomal irinotecan plus fluorouracil/leucovorin: a multicen… DOI 10.1177/17588359241279688↗
- Paper Plasma Chromogranin A as a Prognostic Marker in Pancreatic Ductal Adenocarcinoma. DOI 10.1097/mpa.0000000000001319↗
- Paper The Significance of the Prognostic Nutritional Index for All Stages of Pancreatic Cancer. DOI 10.1080/01635581.2016.1250921↗
- Hee Seung Lee · 5 shared papers, 2016–2024 · strength 0.46
- Paper Survival predictors in patients with pancreatic cancer on liposomal irinotecan plus fluorouracil/leucovorin: a multicen… DOI 10.1177/17588359241279688↗
- Paper Plasma Chromogranin A as a Prognostic Marker in Pancreatic Ductal Adenocarcinoma. DOI 10.1097/mpa.0000000000001319↗
- Paper The Significance of the Prognostic Nutritional Index for All Stages of Pancreatic Cancer. DOI 10.1080/01635581.2016.1250921↗
- Moon Jae Chung · 5 shared papers, 2016–2024 · strength 0.46
- Paper Survival predictors in patients with pancreatic cancer on liposomal irinotecan plus fluorouracil/leucovorin: a multicen… DOI 10.1177/17588359241279688↗
- Paper Plasma Chromogranin A as a Prognostic Marker in Pancreatic Ductal Adenocarcinoma. DOI 10.1097/mpa.0000000000001319↗
- Paper The Significance of the Prognostic Nutritional Index for All Stages of Pancreatic Cancer. DOI 10.1080/01635581.2016.1250921↗
- Jeong Youp Park · 5 shared papers, 2016–2024 · strength 0.46
- Paper Survival predictors in patients with pancreatic cancer on liposomal irinotecan plus fluorouracil/leucovorin: a multicen… DOI 10.1177/17588359241279688↗
- Paper Plasma Chromogranin A as a Prognostic Marker in Pancreatic Ductal Adenocarcinoma. DOI 10.1097/mpa.0000000000001319↗
- Paper The Significance of the Prognostic Nutritional Index for All Stages of Pancreatic Cancer. DOI 10.1080/01635581.2016.1250921↗
- Seungmin Bang · 5 shared papers, 2016–2024 · strength 0.46
- Paper Survival predictors in patients with pancreatic cancer on liposomal irinotecan plus fluorouracil/leucovorin: a multicen… DOI 10.1177/17588359241279688↗
- Paper Plasma Chromogranin A as a Prognostic Marker in Pancreatic Ductal Adenocarcinoma. DOI 10.1097/mpa.0000000000001319↗
- Paper The Significance of the Prognostic Nutritional Index for All Stages of Pancreatic Cancer. DOI 10.1080/01635581.2016.1250921↗
- Si Young Song · 4 shared papers, 2016–2019 · strength 0.28
- Paper Plasma Chromogranin A as a Prognostic Marker in Pancreatic Ductal Adenocarcinoma. DOI 10.1097/mpa.0000000000001319↗
- Paper The Significance of the Prognostic Nutritional Index for All Stages of Pancreatic Cancer. DOI 10.1080/01635581.2016.1250921↗
- Paper Statin Use and Its Impact on Survival in Pancreatic Cancer Patients. DOI 10.1097/md.0000000000003607↗
- Jung Hyun Jo · 2 shared papers, 2019–2024 · strength 0.28
- Jiyoung Keum · 1 shared paper, 2024 · strength 0.18
- Huapyong Kang · 1 shared paper, 2024 · strength 0.18
- Chan Su Park · 1 shared paper, 2024 · strength 0.18
- Jae Hee Cho · 1 shared paper, 2024 · strength 0.18
- Sung Ill Jang · 1 shared paper, 2024 · strength 0.18
- Kyung In Shin · 1 shared paper, 2024 · strength 0.18
- Jae Bock Chung · 2 shared papers, 2016–2017 · strength 0.12
- Bun Kim · 1 shared paper, 2017 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.